• Pfizer Ventures helps gamma delta player ImCheck to $53M round

    8 days ago - By Fierce Biotech

    Pfizer Ventures has co-led a $53 million series B investment in ImCheck, a developer of antibodies focused on gamma delta T cells. ImCheck will use the money to move its lead candidate into the clinic in patients with solid and hematological cancers.
    Read more ...